However, people with pre-existing diabetic retinopathy may be at higher risk for worsening eye conditions when starting tirzepatide
[ 9 , 10 ] However, despite decades of investigation, much of the available evidence comes from laboratory studies, animal models, or relatively small human trials
Theres a reason we stock so many fillers at our practice, and its because we understand that each filler really only does 1 or 2 things best and when you try to use it for other things, its going to require a lot more product (higher cost) and break down way faster than it should
Additionally, some of the smaller subgroup analyses included relatively few events
Not because the compound doesn't work, but because improper storage destroys it before the capsule reaches your mouth